| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-11 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 9e-09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-07 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |